The Challenges of First-in-Human Stem Cell Clinical Trials: What Does This Mean for Ethics and Institutional Review Boards?

Stem cell-based clinical interventions are increasingly advancing through preclinical testing and approaching clinical trials. The complexity and diversity of these approaches, and the confusion created by unproven and untested stem cell-based “therapies,” create a growing need for a more comprehens...

Descripción completa

Detalles Bibliográficos
Autores principales: Barker, Roger A., Carpenter, Melissa K., Forbes, Stuart, Goldman, Steven A., Jamieson, Catriona, Murry, Charles E., Takahashi, Jun, Weir, Gordon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Perspective
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5995446/
https://www.ncbi.nlm.nih.gov/pubmed/29742388
http://dx.doi.org/10.1016/j.stemcr.2018.04.010

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5995446/
https://www.ncbi.nlm.nih.gov/pubmed/29742388
http://dx.doi.org/10.1016/j.stemcr.2018.04.010

Ejemplares similares